SCHEMBL23047411

SCHEMBL23047411

CNc1cc(OC)c(C2CCNCC2)cn1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 3/20 0.48
▸ EHMT2 Q96KQ7 1/20 0.46
▸ EHMT1 Q9H9B1 1/20 0.46
▸ HTR2A P28223 2/20 0.46
▸ HTR1A P08908 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44
▸ SLC6A4 P31645 1/20 0.44
▸ SLC6A3 Q01959 1/20 0.44
▸ CCNT1 O60563 8/20 0.41
▸ CDK9 P50750 8/20 0.41
▸ CHEK1 O14757 4/20 0.41
▸ CDK1 P06493 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ CDK7 P50613 1/20 0.39
▸ CASP7 P55210 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26551345 0.90 GCK (0.43) EHMT2
SCHEMBL21081132 0.79 HTR2C (0.50) HTR2CHTR2AHTR1ASLC6A2SLC6A4
SCHEMBL29752771 0.79 HTR2C (0.50) HTR2CHTR2AHTR1ASLC6A2SLC6A4
Hydrochloric Acid SCHEMBL30440116 0.78 HTR2C (0.51) HTR2CHTR2AHTR1ASLC6A2SLC6A4
Hydrochloric Acid SCHEMBL21045693 0.78 HTR2C (0.51) HTR2CHTR2AHTR1ASLC6A2SLC6A4
SCHEMBL23426724 0.76 HTR2C (0.47) HTR2CHTR2AHTR1ASLC6A2SLC6A4
SCHEMBL24610451 0.76 HTR2C (0.47) HTR2CHTR2AHTR1ASLC6A2SLC6A4
SCHEMBL23047426 0.75 HTR2C (0.42) HTR2CEHMT2EHMT1HTR2AHTR1A
SCHEMBL24610471 0.75 GCK (0.38) CCNT1CDK9CHEK1
SCHEMBL26548534 0.74 PDE10A (0.45) HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3786160-B1 PYRIDINE DERIVATIVES AND THERAPEUTIC USES THEREOF AS TRPC6 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2022-07-13 — — EP disclosed
EP-3786160-A1 PYRIDINE DERIVATIVES AND THERAPEUTIC USES THEREOF AS TRPC6 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2021-03-03 — — EP disclosed
Send feedback